Claudin 18.2 (CLDN18.2) expression prevalence, prognostication and clinical variables in gastric and gastroesophageal junction adenocarcinoma patient samples

Sewastjanow, M; Yamashita, K; Iwata, KK; Moran, D; Elsouda, D; Pizzi, M; Vicentini, ER; Shanbhag, N; Ta, A; Waters, R; Chatterjee, D; Ajani, J

CANCER RESEARCH, 2023; 83 (7):